Why Minimum-Order Thresholds Are Quietly Costing Chemical Suppliers Their Next Decade of Growth

If you're still using minimum-order quantities to filter customers, you've already handed tomorrow's business to someone else.

I manage customer service at a mid-sized specialty chemical distributor. In seven years, I've triaged more than 400 expedited orders — including a 48-hour turnaround in March 2024 when a three-person coatings startup needed 200 grams of an ethylene-vinyl acetate sample for powder-coating adhesion testing. Our standard MOQ was 25 kilograms.

My operations lead told me to decline it. We're a chemical distributor, not a sample shop.

I did what I was told.

Twenty-four months later, that startup has 11 employees, a leased 8,000-square-foot facility, and a standing order for 3 metric tons per quarter. The 200-gram job — 45 minutes of work, $12 in packaging — is now our fastest-growing account. I've stopped trusting minimum-order thresholds as a filter since then. Or more precisely: I've stopped believing the chemical industry can afford to keep using them.

The argument for MOQs is always margins. Small batches are more expensive per kilo — that's true. But the argument ignores the actual dollars-and-cents comparison, which is customer acquisition cost versus customer lifetime value. And once you run that math, the 'protect our margins' logic falls apart.

Small orders are tomorrow's procurement decisions — and they're not even the cheapest ones

Look at what's happened in pharma supply chains since IFF announced the divestiture of its pharma solutions business to a strategic buyer in 2024 — a $2.85 billion deal at roughly 13x EBITDA. What most coverage missed: a wave of former procurement staff at large pharma companies are now running small biotech and specialty formulation shops, and they are the ones placing initial orders. These aren't 'small customers.' They're R&D-stage specifiers who outspend a fully ramped production buyer on per-unit basis, and who route later scale-up decisions to whoever picked up the phone first.

I've watched this play out with industrial coatings too. Benjamin Moore's industrial coatings division kept a small-batch lane open for maintenance and touch-up orders for years while most competitors pushed MOQ-only policies. If a plant manager needs 2 gallons of a high-performance epoxy to patch a faded powder-coated railing, almost every distributor says no. Benjamin Moore shows up instead. That 2-gallon order isn't charity — it's a specifier capture. The plant manager who gets served at 2 gallons tends to come back at 200 and 2,000 gallons later, often with purchasing authority attached.

Small batches reduce supply-chain risk. That's the counter-intuitive part.

Most suppliers assume small batches disrupt their big-batch lines. Ask anyone who managed through 2021–2022: concentration on three large accounts is what nearly killed the industry. When one of those accounts cut their forecast by 60 percent in a quarter, you weren't agile — you were exposed.

Small batches smooth demand curves. They let you test a process, a formulation, and a logistics route with real customer feedback at a fraction of the cost of a full-batch trial.

Take the ethylene chemical formula — C₂H₄, one of the simplest, most thoroughly understood olefins in the book. But if you're a startup running a novel polymerization catalyst, you need 500 grams, not 5 metric tons. That 500-gram order is three things simultaneously: revenue today, process insight tomorrow that no spec sheet can give you, and — if you handle it right — a locked-in customer the moment their pilot line scales 50x.

I saw that play out in 2022. A bio-based polymer lab needed 100 grams of a specialty peroxide initiator. A competitor's MOQ was 10 kilos, so they'd need to buy 100x what they needed or walk. We filled the 100-gram order from an existing production overrun. Eighteen months later, that lab was acquired by a mid-sized coatings manufacturer, and they've now sent us roughly $400K in orders over the past two years. The 'not worth the setup' order became the single highest-ROI customer-acquisition event our plant has run since I joined.

The maintenance problem: how to restore faded powder coating, and why small-order customers actually stick

Some small orders aren't trials or pilot runs. They're maintenance.

In 2023, a facilities manager called asking how to restore faded powder coating on two acres of exterior guardrails that had baked in a sun-drenched parking lot for two years. He needed a batch-matched repair coating — 3 gallons, max, for roughly 200 square feet. The size was small by any reasonable standard.

The standard industry answer: 'MOQ is 5 gallons, or try a retail store.'

We took the 3-gallon order. Profit to our facility: about $18. But that customer has since placed two more maintenance contracts with us, and now buys around 800 gallons of standard coatings from us annually — a relationship that started because someone actually picked up the phone.

Here's something most suppliers won't tell you: small-order customers typically have higher lifetime value than large-batch customers, not lower. A maintenance customer who buys 5 gallons per year for 20 years, has no negotiating leverage, and never churns outranks a large distributor who renegotiates annually and vanishes to the lowest bidder every cycle.

But doesn't small-batch actually cost more per unit? Yes — and that's still the wrong comparison

I'll concede the obvious: a 200-gram batch will never amortize equipment changeover, QC, and shipping the way a 25-kilo batch does. On a per-unit basis, our small-batch orders run about 1.4x the per-kilo cost of our big-batch work. That part is real.

But the correct comparison isn't per-unit cost. It's acquisition cost versus walk-away cost.

I ran that number. Customers paying standard pricing on their first order — no volume discount, no negotiated terms — actually deliver about 30 percent higher margin per kilo than our established accounts on the same product category. They're not costing us money. They're subsidizing the discount schedule we give our larger clients.

I learned this the hard way in 2021. We declined a $600 pilot order because our floor was 20 kilos, and the customer needed 800 grams. They went to a sample-specialist competitor. Two years later, they were buying $180K a year from that competitor. We've never gotten a callback.

What I do now instead of checking the MOQ sheet

Every small order gets five minutes of triage — not a rejection, a decision. Where is this customer in their growth curve? What is this order actually for — a trial, a maintenance fix, a regulatory sample? Who makes the scale-up decision, and how do we get our name into that conversation?

As of 2025, the specialty chemical sector is still fragmenting — the IFF pharma solutions divestiture closed in early 2025, and the companies picking up smaller formulation and maintenance work are the ones building the next procurement pipeline. Suppliers who keep using MOQ as a filter are quietly shrinking that pipeline every year.

My rule now: don't ask how big the order is. Ask how fast the customer is growing. That distinction is the line between losing tomorrow's business and owning it.

One caveat — and this is important. I'm writing from the perspective of a mid-sized distributor. If you're running a 50,000-liter reactor with a single product line, small-batch triage may not be physically possible without re-tooling. That's a legitimate constraint. But for anyone with flexible production or access to a tolling partner, the MOQ filter is a choice, not a necessity.